|
DDX27 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.494350E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.511680E-02 |
| Normal-vs-Stage2 |
3.370800E-01 |
| Normal-vs-Stage3 |
3.869600E-01 |
| Normal-vs-Stage4 |
4.021400E-03 |
| Stage1-vs-Stage2 |
4.658200E-01 |
| Stage1-vs-Stage3 |
1.880210E-01 |
| Stage1-vs-Stage4 |
2.221000E-01 |
| Stage2-vs-Stage3 |
8.105200E-01 |
| Stage2-vs-Stage4 |
1.389750E-01 |
| Stage3-vs-Stage4 |
4.555800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.608000E-02 |
| Normal-vs-AfricanAmerican |
6.275700E-03 |
| Normal-vs-Asian |
1.592620E-01 |
| Caucasian-vs-AfricanAmerican |
5.324200E-02 |
| Caucasian-vs-Asian |
5.682200E-01 |
| AfricanAmerican-vs-Asian |
7.306400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.379900E-02 |
| Normal-vs-Female |
7.077800E-03 |
| Male-vs-Female |
1.982040E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.147800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.322380E-02 |
| Normal-vs-Age(61-80Yrs) |
1.805920E-02 |
| Normal-vs-Age(81-100Yrs) |
6.382000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.010000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.430800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.326000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.036400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.238200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.008800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.846100E-04 |
| Normal-vs-Grade 2 |
1.805720E-02 |
| Normal-vs-Grade 3 |
7.673900E-02 |
| Normal-vs-Grade 4 |
1.144800E-01 |
| Grade 1-vs-Grade 2 |
4.115900E-03 |
| Grade 1-vs-Grade 3 |
2.136000E-03 |
| Grade 1-vs-Grade 4 |
5.764200E-03 |
| Grade 2-vs-Grade 3 |
5.796200E-01 |
| Grade 2-vs-Grade 4 |
8.303800E-01 |
| Grade 3-vs-Grade 4 |
8.522800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.775200E-03 |
| Normal-vs-ccB subtype |
7.870600E-01 |
| ccA subtype-vs-ccB subtype |
1.365870E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.220200E-01 |
| Normal-vs-N1 |
2.948200E-01 |
| N0-vs-N1 |
7.069400E-01 |
|
|
